This afternoon, KBL Merger Co. IV (KBLM), released the details of their shareholder vote, held today to approve moving their previously extended deadline from April 9, 2020, to July 9, 2020. This was KBLM’s fourth deadline extension, but it was approved with a minimal number of redemptions.
Per the 8-K, 67,665 public shares exercised their right to redeem at a price of $10.77195 and as a result, approximately $728,884 was removed from the trust account. A total of approximately $11.3 million will remain.
Additionally, the sponsors previously agreed to contribute a maximum of $55,000 to trust each month for shareholders that did not redeem at today’s vote. Based on the number of shareholder left post-vote, that means that the sponsors will now be contributing approximately $0.05255 per month, or a total of $0.1577 if they need the full three months to complete their transaction.
KBLM now has until July 9th to close its deal with CannBioRx.
FIGX Acquisition Corp. (NASDAQ:FIGXU) announced the pricing of its $131 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “FIGXU”, Friday, June 27, 2025. The new SPAC aims to seek out a financial services target with a particular focus on wealth and asset managers with the potential to...
Yorkville Acquisition Corp. (NASDAQ:YORKU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “YORKU”, Friday, June 27, 2025. The new SPAC plans to combine with a target company in the telecom, media or technology sectors. Yorkville Acquisition Corp.’s management team is led...
At the SPAC of Dawn As pressure on Fed Chairman Jerome Powell increases, the market is set to ingest a raft of new indicators today as well as hear from Cleveland Fed President Beth Hammack on the potential interest rate path. Today will also see June’s 8th SPAC IPO as Cantor Equity Partners III Inc....
Cantor Equity Partners III Inc. (NASDAQ:CAEP) announced the pricing of its upsized $240 million IPO and its shares are expected to begin trading on the Nasdaq under the symbol “CAEP”, Thursday, June 26, 2025. The new SPAC plans to combine with a target company in an industry where its management has relevant expertise such financial...
Launch One (NASDAQ:LPAA) has entered into a definitive agreement to combine with biotech firm Minovia Therapeutics at a $180 million pre-money valuation. Haifa, Israel-based Minovia is developing a drug platform based on mitochondrial cell therapies to potentially treat rare disorders as well as the effects of aging and other causes of bodily degeneration. The combined...